Structural dynamics and immunogenicity of the recombinant and outer membrane vesicle-embedded Meningococcal antigen NadA
Valeria CalvaresiiD, Lucia Dello IaconoiD, Sara BorghiiD, Enrico Luzzi, Alessia BiolchiiD, Barbara Benucci, Ilaria Peschiera, Fabiola GiustiiD, Lucia Eleonora FontanaiD, Zhong-Yuan KaniD, Zaira SpinelloiD, Marcello MerolaiD, Isabel Delany, Kasper Dyrberg RandiD, Nathalie NoraisiD
Abstract
The structure and conformation adopted by protein vaccine antigens significantly influence the exposure of their antigenic determinants. Structural knowledge of antigens in native state could drive the design of recombinant vaccines that resemble their cognate native forms, although such information is often difficult to obtain, particularly for membrane proteins. Here, we assessed the structural and functional features of the native Neisseria Adhesin A (NadA), a meningococcal trimeric outer membrane protein included as soluble recombinant antigen in the 4CMenB vaccine. We used hydrogen-deuterium exchange mass spectrometry (HDX-MS) to generate a structural model of NadA and to compare the fold and structural dynamics of the recombinant NadA as soluble vaccine form, and the native NadA in situ, as embedded in meningococcal outer membrane vesicles (OMVs), complementing the HDX data with electron microscopy imaging. While their overall structures are similar, conformational differences between the two forms were observed. Especially, OMV- embedded NadA appears more susceptible to trimer opening than its cognate soluble antigen, suggesting that NadA in its native membrane could display a larger antigenic surface. Accordingly, we show that mice immunized with OMV-embedded NadA elicited antibodies with superior bactericidal activity and capable of better preventing bacterial adhesion compared to the soluble antigen. Collectively, these data support the hypothesis that protein vaccine antigens presented in native-like environments can elicit a more potent immune response than recombinant forms.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 8
- FWCI
- 18.39
- Field percentile
- top 1%
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- New strategy to select cross-reactivity Meningococci strains: immunization with Outer membrane vesicles of serogroup C and cationic lipid as adjuvant
A. I. Portilho, G. Trzewikowski de Lima, E. De Gaspari·bioRxiv·May 17, 2021
- Immunogenicity and protective efficacy of an intranasal neuraminidase-based influenza virus vaccine adjuvanted with bacterial cell membrane-derived adjuvants
Kirill Vasilev, Irene Hoxie, … Florian Krammer·bioRxiv·Feb 26, 2025
- Structural Design of Chimeric Antigens for Multivalent Protein Vaccines
Sarah Hollingshead, Ilse Jongerius, … Christoph M. Tang·Nature CommunicationsPeer-reviewed·Mar 7, 2018
- Group B meningococcal outer membrane protein vaccine promote potent anti-viral effect
- Structure-activity of outer membrane proteins in native bacterial membrane vesicles by solid-state NMR
Tata Gopinath, Kyungsoo Shin, … Francesca M. Marassi·bioRxiv·Jul 16, 2026
- Cell-free expression of Nipah virus transmembrane proteins for proteoliposome vaccine design
Vivian T. Hu, Shahrzad Ezzatpour, … Neha P. Kamat·ACS NanoPeer-reviewed·Jun 3, 2025